Comment on Why Geron Corp. Is Rallying 10% Today

Why Geron Corp. Is Rallying 10% Today

After the company updated investors on its clinical-stage progress on Monday, shares in Geron Corp. (NASDAQ: GERN) have more than doubled, including a 10% increase today as of 11:45 a.m. EDT. Patients with life-threatening hematologic myeloid malignancies, including myelofibrosis, have limited treatment options and a poor prognosis, so there's a big need for new treatment options, such as Geron Corp.'s imetelstat, which is currently in phase 2 studies and licensed to Johnson & Johnson (NYSE: JNJ).IMAGE SOURCE: GETTY IMAGES.Continue reading

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News